BUSINESS

• JCR Shooting for Big Chunk of 900 Billion Yen Global Lysosome Storage Disease Market with J-Brain Cargo
  March 27, 2018

• Mitsubishi Tanabe Aims to Attain Efficiency in Clinical Trials through Full-Fledged Use of Hitachi’s AI Technology
  March 27, 2018

• Japan Approves 1st Herceptin Biosimilar for Gastric Cancer
  March 26, 2018

• Shionogi Partners with CARB-X to Fight CRE Superbug
  March 23, 2018

• Thomas-Peter Hausner Named Next President of Bayer Holdings Japan
  March 23, 2018

• Lilly Japan Sales Up 7% in 2017, Upbeat Biz Fueled by Global Simultaneous Development
  March 23, 2018

• Eldecalcitol NDA Accepted in China: Chugai
  March 23, 2018

• J-TEC’s Cell Sheet JACE Filed for Epidermolysis Bullosa
  March 23, 2018

• EA Pharma, Irish Cosmo Technologies Hook Up on Colonoscopy Products
  March 23, 2018

• Single Generic Pricing Rule Will Accelerate Unreasonable Price Raises: Sawai Chief
  March 22, 2018

• Takeda Global Headquarters Completed
  March 22, 2018

• Mircera 12.5μg Version Approved in Japan: Chugai
  March 22, 2018

• Life Science Institute to Launch Cell Processing Center for Muse Cells, Aiming to Commence Operations in Jan. 2019
  March 22, 2018

• Toho Forms Capital Alliance with Tokyo Upstart HekaBio
  March 20, 2018

• Hitachi Chemical Wins Clinical Regenerative Medicine Manufacturing Deal from Daiichi Sankyo
  March 20, 2018

• Opdivo Picks Up HCC Nod in Taiwan
  March 20, 2018

• Top Court Slaps Down Debiopharm’s Appeal over Elplat Patent
  March 20, 2018

• Xtandi Gets FDA Priority Review Status for Add’l CRPC Indication
  March 20, 2018

• IBL, Astellas Wind Up Human Fibrinogen Collaboration
  March 20, 2018

• Bioverativ Earns Approval for 4,000 IU Version for Hemophilia B Treatment Alprolix
  March 20, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 393
• 394
• 395
• 396
• 397
• 398
• 399
• 400
• 401
• …
• Next ›
• 最終 »